Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 534
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 51–100 of 202 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05790200	Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma	unknown	Phase 2	30	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1	Mar 30, 2023	clinicaltrials
NCT04974866	Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma	unknown	Phase 2	20	Qingdao Central HospitalOTHER	1	Mar 29, 2023	clinicaltrials